Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

ROR1 and ROR2 are Wnt receptors that are critical for β-catenin-independent Wnt pathways and have been linked to processes driving tumor progression, such as cell proliferation, survival, invasion, and therapy resistance. Both receptors have garnered interest as potential therapeutic targets since they are largely absent in adult tissue, are overexpressed in several cancers, and, as members of the receptor tyrosine kinase family, are easier to target than all other components of the pathway. Unlike ROR1 which always promotes tumorigenesis, ROR2 has a very complex role in cancer acting either to promote or inhibit tumor progression in different tumor types. In the present article, we summarize the findings on ROR2 expression in cancer patients and its impact on clinical outcome. Further, we review the biological processes and signaling pathways regulated by ROR2 that explain its dual role in cancer. Finally, we describe the ongoing strategies to target ROR2 in cancer. Copyright © 2022 Elsevier B.V. All rights reserved.

Citation

María Victoria Castro, Pablo Lopez-Bergami. Cellular and molecular mechanisms implicated in the dual role of ROR2 in cancer. Critical reviews in oncology/hematology. 2022 Feb;170:103595

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 35032666

View Full Text